documented a reduced level of Ng in AD (254 ± 69 pg/ml) compared to the control (2099 ± 540 pg/ml) in NDEs, which was also significantly associated with cognitive decline (R2 = 0.60; P < 0.0001).63 This evidence concerns the gene NRGN and Alzheimer disease.